HER2 POSITIVE

Clinical trials for HER2 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new HER2 POSITIVE trials appear

Sign up with your email to follow new studies for HER2 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug zanidatamab aims to shrink early breast cancer tumors before surgery

Disease control Recruiting now

This phase 2 trial is testing a drug called zanidatamab in 20 people with early-stage, low-risk HER2-positive breast cancer. The drug is given intravenously, along with hormone therapy pills (letrozole or tamoxifen). The main goal is to see if the cancer disappears completely by …

Matched conditions: HER2 POSITIVE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

HER2 POSITIVE

Get alerted when new HER2 POSITIVE trials appear

New drug zanidatamab aims to shrink early breast cancer tumors before surgery